STANDARDS OF BUSINESS CONDUCT
We take our responsibility to comply with all applicable legal requirements very seriously. As a leading provider of technologies and services to the global pharmaceutical, biotechnology and consumer healthcare industry we conduct all our business responsibly and with integrity. Our customers, investors and suppliers count on it, and our company’s continued success depends on it.
Our Standards of Business Conduct and our Environment, Health & Safety Policy commit Catalent to minimize our impact on the environment, complying with relevant laws, and operating with the required environmental permits, approvals, and controls. Our Standards of Business Conduct, available in multiple languages, is the foundation of the program of how we work responsibly and with integrity. It is authorized and supported by the Catalent Board of Directors and the senior leadership of Catalent. Overall responsibility for the ethics and compliance program rests with the General Counsel and Chief Compliance Officer, with oversight from the Audit Committee of the Board of Directors.
We offer an independent third-party Business Conduct Line that is available 24 hours-a-day, seven days-a-week to employees and third parties to confidentially and, where legally permitted, if desired, anonymously raises concerns about the business conduct of Catalent and its employees. Concerns can be raised via CatalentMSW.com or via telephone. If in the United States, call (800) 461 9330. Outside of the United States, use the International Phone Numbers list to find the direct dial number. (NOTE: in some countries, such as France and Belgium, the Business Conduct Line should only be used to report serious concerns regarding financial integrity or senior management. All other concerns in these countries should be directed to local management.) Multilingual representatives are available; however, you may need to wait briefly while an appropriate representative is brought on the line.
In addition to the Business Conduct Line, you may also submit written concerns or reports of possible violations regarding accounting, auditing, internal controls or financial reporting to the Head of Internal Audit or the chairperson of the Catalent Audit Committee of the Board of Directors:
Catalent Pharma Solutions
c/o General Counsel
14 Schoolhouse Road Somerset, NJ 08873 USA
2021 ANNUAL COMPLIANCE CERTIFICATION
Catalent has established a comprehensive compliance program, applicable to all its direct and indirect subsidiaries, that is designed to prevent, detect and promptly address any instances of misconduct, in accord with the US Dept. of Health and Human Services’ Office of Inspector General’s “Compliance Program Guidance for Pharmaceutical Manufacturers” 68 CFR 23731. Catalent’s Compliance Program is reasonably tailored to the size, organizational structure and resources of Catalent and built upon our corporate values of conducting all our business with uncompromising integrity, personal accountability and respect for others.
To read the full certification, please click here.
CORPORATE RESPONSIBILITY GOVERNANCE
We have a clear governance structure to manage our corporate responsibility activities and we listen to stakeholders to help us identify our priorities.
MANAGING CORPORATE RESPONSIBILITY
Environmental and social responsibility have always been integral to our core values. However, to further that alignment, we established the Office of Corporate Responsibility in fiscal 2017 and created a formal governance structure through our CR Council, which reports to me. Composed of members of our senior leadership, the Council oversees the implementation of our CR strategy and commitments across our business.
As we began to focus on CR, we worked to understand the environmental, social and governance (ESG) priorities of our stakeholders and align wherever appropriate with their values. For example, we joined the Pharmaceutical Supply Chain Initiative to partner with our customers to continually improve the environmental, social and ethical performance of the pharmaceutical supply chain.
Three subcommittees of the CR Council—the sustainability team, the grant-making committee, and the community ambassador network—help drive progress in three critical areas of our overall CR commitment and embed CR deeper into our business. The global Corporate Responsibility Director formally reports to the President and Chief Operating Officer.
Our CR strategy stands on four pillars—Innovation, People, Environment and Communities— and we have instituted a scorecard approach to monitor how each of the business units and sites across the Catalent network contributes to meeting our goals.
LISTENING TO STAKEHOLDERS
We focus on the corporate responsibility issues we believe to be most significant to our business. Our view is informed by stakeholder feedback, regulatory developments, and issues that appear to engage our constituencies.
Relevant issues on which we have recently focused include:
- Community investment and philanthropy
- Diversity and inclusion
- Energy use and climate change
- Occupational health and safety
- Product quality and safety
- Talent attraction and retention
- Training and development
Finally, we address corporate responsibility issues by participating in organizations, such as: